Laura de Oliveira Semeão Selected Research

Aryldialkylphosphatase (Paraoxonase)

2/2022	Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis.
2/2022	Correction to: Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
1/2021	Menstruation distress is strongly associated with hormone-immune-metabolic biomarkers.
1/2021	Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation.
11/2020	Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
5/2020	Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura de Oliveira Semeão Research Topics

Disease

4	Schizophrenia (Dementia Praecox) 02/2022 - 05/2020
3	Psychotic Disorders (Schizoaffective Disorder) 02/2022 - 05/2020
1	Stroke (Strokes) 01/2023
1	Ischemic Stroke 01/2023
1	Hippocampal Sclerosis 02/2022
1	Temporal Lobe Epilepsy 02/2022
1	Colic (Abdominal Cramps) 01/2021
1	Muscle Cramp (Cramp) 01/2021
1	Pain (Aches) 01/2021
1	Premenstrual Syndrome (Premenstrual Tension) 01/2020

Drug/Important Bio-Agent (IBA)

6	Aryldialkylphosphatase (Paraoxonase)IBA 02/2022 - 05/2020
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Malondialdehyde (Propanedial)IBA 02/2022 - 05/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022 - 05/2020
3	Immunoglobulin M (IgM)IBA 02/2022 - 05/2020
2	AntioxidantsIBA 01/2023 - 11/2020
2	arylesteraseIBA 02/2022 - 01/2021
2	Progesterone FDA LinkGeneric 01/2021 - 01/2020
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2023
1	phenyl acetateIBA 02/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	HaptoglobinsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Plasminogen InactivatorsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	Immunoglobulin A (IgA)IBA 11/2020
1	Advanced Oxidation Protein Products (AOPP)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	LipidsIBA 11/2020
1	CytokinesIBA 05/2020
1	Interleukin-4 (Interleukin 4)IBA 05/2020
1	EnzymesIBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 05/2020